RayzeBio, a Bristol Myers Squibb company, is developing transformative radiopharmaceutical therapies to offer new hope for patients living with cancer.
Base: $306,814 - $371,787; Bonus/Equity: Additional incentive cash and stock opportunities may be available; Benefits: Health Coverage, Wellbeing Support, Financial Well-being and Protection, Work-life benefits
Must-have
Nice-to-have
Not specified